Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03724032 · ClinicalTrials.gov registry record · NA
Investigation and Modulation of the Mu-opioid Mechanisms in TMD (in Vivo)
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03724032 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 15 participants.
The verdict
NCT03724032, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
In this study, this team of researchers will investigate the impact of chronic temporomandibular disorder suffering on the endogenous μ-opioid system in vivo, arguably one of the principal endogenous pain modulatory systems in the brain, and its modulation by 10 daily sessions of primary motor cortex stimulation using high-definition transcranial direct current stimulation (HD-tDCS).
Interventions
- DEVICE HD-tDCS*
- DEVICE Sham HD-tDCS*
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-12-13 |
| Est. Completion | 2022-01-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03724032
The ClinicalTrials.gov registry entry for NCT03724032 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HD-tDCS* is the first listed.
NCT03724032 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03724032 about?
NCT03724032 is a clinical study titled "Investigation and Modulation of the Mu-opioid Mechanisms in TMD (in Vivo)". In this study, this team of researchers will investigate the impact of chronic temporomandibular disorder suffering on the endogenous μ-opioid system in vivo, arguably one of the principal endogenous pain modulatory systems in the brain, and its modulation by 10 daily sessions of primary motor corte...
What is the current status of trial NCT03724032?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2018-12-13. Estimated completion is 2022-01-17.
What interventions are being tested in trial NCT03724032?
The interventions under investigation include: HD-tDCS* (DEVICE), Sham HD-tDCS* (DEVICE).
Who is sponsoring clinical trial NCT03724032?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.